title: New developments in conditioning regimens before auto-SCT in multiple myeloma.
abstract: The current standard conditioning regimen before auto-SCT in patients with multiple myeloma is melphalan 200 mg/m(2). Several attempts have recently been made to improve this aspect of the high-dose therapy procedure. The scope of this review article is to summarize current knowledge on conditioning regimens in this setting.
authors.affiliation: Hematology Department, University Hospital Hôtel-Dieu, Nantes, France. philippe.moreau@chu-nantes.fr
authors.forename: P
authors.initials: P
authors.lastname: Moreau
authors.forename: M
authors.initials: M
authors.lastname: Attal
authors.forename: J L
authors.initials: JL
authors.lastname: Harousseau
mesh_terms: D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D006801:Humans; D008558:Melphalan / Q000008:administration & dosage*; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000601:surgery; D033581:Stem Cell Transplantation / Q000379:methods*; D019172:Transplantation Conditioning / Q000379:methods*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D008558:Melphalan